EP

Eversept Partners Portfolio holdings

AUM $992M
1-Year Est. Return 2.54%
This Quarter Est. Return
1 Year Est. Return
+2.54%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$884M
AUM Growth
-$85.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
75
New
Increased
Reduced
Closed

Top Buys

1
+$47.5M
2
+$18.5M
3
+$16.2M
4
GKOS icon
Glaukos
GKOS
+$15.6M
5
CYH icon
Community Health Systems
CYH
+$15.2M

Top Sells

1
+$40.2M
2
+$17.2M
3
+$15.8M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$12.8M
5
EW icon
Edwards Lifesciences
EW
+$12.6M

Sector Composition

1 Healthcare 98.66%
2 Financials 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBYI icon
51
Puma Biotechnology
PBYI
$263M
$816K 0.08%
275,788
-720,314
ALEC icon
52
Alector
ALEC
$152M
$759K 0.08%
617,418
+417,323
EHTH icon
53
eHealth
EHTH
$161M
$596K 0.06%
+89,220
AUTL
54
Autolus Therapeutics
AUTL
$407M
$533K 0.05%
343,947
+245,052
ACIU icon
55
AC Immune
ACIU
$327M
$188K 0.02%
+100,752
ABSI icon
56
Absci
ABSI
$638M
– –
-199,464
ARQT icon
57
Arcutis Biotherapeutics
ARQT
$2.41B
– –
-191,158
AZN icon
58
AstraZeneca
AZN
$258B
– –
-102,661
DHR icon
59
Danaher
DHR
$158B
– –
-22,209
DXCM icon
60
DexCom
DXCM
$27.6B
– –
-148,688
EOLS icon
61
Evolus
EOLS
$439M
– –
-383,045
EW icon
62
Edwards Lifesciences
EW
$44.7B
– –
-170,678
GH icon
63
Guardant Health
GH
$9B
– –
-276,036
HSIC icon
64
Henry Schein
HSIC
$7.74B
– –
-80,303
MEDP icon
65
Medpace
MEDP
$17B
– –
-19,049
MREO
66
Mereo BioPharma
MREO
$318M
– –
-777,890
SPY icon
67
SPDR S&P 500 ETF Trust
SPY
$672B
– –
0
SUPN icon
68
Supernus Pharmaceuticals
SUPN
$2.96B
– –
-105,581
TLT icon
69
iShares 20+ Year Treasury Bond ETF
TLT
$49.2B
– –
0
TSVT
70
DELISTED
2seventy bio
TSVT
– –
-1,003,678
VTRS icon
71
Viatris
VTRS
$12.1B
– –
-1,272,102
XENE icon
72
Xenon Pharmaceuticals
XENE
$3.14B
– –
-155,540
XRAY icon
73
Dentsply Sirona
XRAY
$2.62B
– –
-139,656
ZLAB icon
74
Zai Lab
ZLAB
$2.93B
– –
-102,930
PDCO
75
DELISTED
Patterson Companies, Inc.
PDCO
– –
-146,051
1 2
3